Concord Biotech Limited (CONCORDBIO.BO)
INR 1719.65
(-1.27%)
INR 1719.65
(-1.27%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.74 Billion INR | -22.29% |
| 2022 | 2.23 Billion INR | 6.88% |
| 2021 | 2.09 Billion INR | 14.41% |
| 2020 | 1.83 Billion INR | 7.57% |
| 2019 | 1.7 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -15.26 Billion INR | -977.06% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.74 Billion INR | 0.0% |
| 2023 Q2 | 1.96 Billion INR | 0.0% |
| 2023 FY | 1.74 Billion INR | -22.29% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | 0.0% |
| 2022 FY | 2.23 Billion INR | 6.88% |
| 2022 Q4 | 2.23 Billion INR | 0.0% |
| 2021 FY | 2.09 Billion INR | 14.41% |
| 2020 FY | 1.83 Billion INR | 7.57% |
| 2019 FY | 1.7 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.36 Billion INR | -27.434% |
| Biocon Limited | 307.95 Billion INR | 99.435% |
| Blue Jet Healthcare Limited | 2.13 Billion INR | 18.519% |
| Dishman Carbogen Amcis Limited | 39.53 Billion INR | 95.598% |
| FERMENTA BIOTECH LIMITED | 2.62 Billion INR | 33.733% |
| GENOMIC VALLEY BIOTECH LIMITED | 7.91 Million INR | -21888.415% |
| Lyka Labs Limited | 884.58 Million INR | -96.773% |
| Panacea Biotec Limited | 4.02 Billion INR | 56.703% |
| SAMSRITA LABS LIMITED | 32.93 Million INR | -5185.046% |
| Servoteach Industries Limited | 5275.00 INR | -32997625.118% |
| SMS Lifesciences India Limited | 1.96 Billion INR | 11.591% |
| Supriya Lifescience Limited | 1.05 Billion INR | -64.412% |
| Syngene International Limited | 18.93 Billion INR | 90.809% |
| TAKE Solutions Limited | 969.78 Million INR | -79.487% |
| Titan Biotech Limited | 231.28 Million INR | -652.584% |
| Transgene Biotek Limited | 393.11 Million INR | -342.783% |
| Vanta Bioscience Limited | 724.23 Million INR | -140.34% |